What’s inside:
Most hospitals think they have visibility. They don’t.
- Why clinical governance breaks without integrated data
- How physician behavior creates hidden variation
- Where financial distortion actually begins
A Guest post by: Dr. Geoffrey P. Cole
What High-Performing Hospitals Do Differently
As a neurosurgeon and later a Chief Medical Officer of Piedmont Rockdale Hospital, I experienced healthcare from two distinct vantage points: the autonomy of clinical decision-making and the accountability of enterprise leadership.
Both perspectives are essential. But without reliable data connecting them, aligned clinical governance in healthcare becomes fragile.
Leading efforts focused on quality metrics, patient satisfaction, credentialing discipline, and supply utilization required more than collaboration. National healthcare policy leaders have emphasized that high-performing health systems depend on continuous performance measurement and system-level accountability as foundational to quality improvement. Disciplined governance must be anchored in measurable performance — and that governance is only as strong as the data supporting it.
When I began my administrative tenure, my charge was clear: bring greater systemization to the hospital and its medical staff. While conversations were sometimes difficult, many operational improvements were achievable. Standardizing physician preference items, however, proved far more nuanced.
Physicians develop attachments to specific supplies — often implantable devices — through direct involvement in their design, creation, or even ownership. These relationships are not inherently problematic or always transparent. And without visibility, assumptions fill the gaps, and governance becomes difficult.
“Partial visibility is more dangerous than no visibility at all.”
Why Clinical Governance in Healthcare Requires Integrated Data Visibility
To address the complexity of clinical governance in healthcare, we moved toward a model of data-driven clinical governance. Clinical Governance Councils (CGCs) were developed across multiple specialty disciplines. In these forums, data and evidence — not personal preference — carry the argument for change. These councils convene regularly to share insights, analyze performance data, and make strategic decisions that improve care across the network. 
As medical liaison to several councils, I drew from my background as a neurosurgeon, my role in supply chain leadership, and my position as a CMO. This was a unique and invaluable combination, and my clinical and administrative credibility was essential for productive dialogue with physician members. But while my credibility may have opened the conversation, it was data that advanced it.
The effectiveness of these councils depended entirely on comprehensive data visibility into utilization and outcomes. When cardiologists, for example, can review utilization patterns for stents, defibrillators, and pacemakers alongside procedural outcomes, they can identify opportunities for standardization that improve both care quality and efficiency.
The same logic applies across every specialty: neurosurgeons analyzing implant performance, orthopedic surgeons reviewing joint replacement outcomes, and interventional radiologists examining procedure success rates all depend on accurate, actionable data that connects clinical decisions to patient results.
Without the foundation of data, governance becomes opinion-based, but with it, peer review becomes disciplined.
The Cost of Blind Spots in Hospital Performance
Leaders who believe they have visibility into system performance without comprehensive, real-time data are often operating with blind spots.
Incomplete supply chain insight or fragmented charge capture creates distortions that ripple across the organization:
- Utilization patterns appear stable when they are not.
- Revenue leakage goes undetected.
- Forecast purchasing becomes reactive rather than predictive.
- Vendor negotiations occur without full leverage.
- Financial performance reflects assumptions rather than actual behavior.
In my experience, when discussing clinical governance in healthcare, partial visibility is more dangerous than no visibility at all. It creates false confidence.
Insight into only part of the supply chain provides a distorted view of cost drivers, physician behavior, and procedural variation. Those distortions directly affect financial integrity and long-term planning.
Supply Chain as a Strategic Lever
The intersection of data-driven clinical governance and supply chain management is where disciplined data becomes transformative.
Product standardization decisions must balance clinical efficacy, patient safety, and responsible resource stewardship. When clinicians and supply chain leaders collaborate and deliberate with transparent, trusted data, unnecessary variation can be reduced without compromising physician judgment. However, if supply chain data is delayed, incomplete, or siloed, collaboration weakens. Vendor relationships are negotiated from a position of uncertainty. Contract compliance becomes difficult to enforce. Forecasting accuracy declines. Enterprise strategy suffers.
“Data does not simply inform governance — it determines whether governance is effective.”
Discipline, Transparency, and Financial Integrity
Sustainable improvement comes from structure: recurring review forums, measurable benchmarks, and high expectations for practitioner conduct. But structure alone is insufficient.
Governance must be powered by integrated data that connects utilization, outcomes, cost, and revenue capture in real time. Only then can leaders act with clarity rather than assumption.
In my tenure, I saw how Clinical Governance Councils provided the framework. But it was comprehensive data visibility that made the framework actionable. When reliable data connects clinical actions to patient outcomes, and flows between domains, providers and executives alike can make decisions that are disciplined, transparent, and scalable, and truly advance the quality of care.
Health system leaders should ask themselves whether their current governance forums are supported by comprehensive, trusted data across utilization, outcomes, and revenue capture. If not, even disciplined structures may be operating with incomplete visibility, thereby limiting alignment, weakening forecasting, and reducing vendor leverage.
Clinical governance in healthcare, particularly when structured as data-driven clinical governance, is only as effective as the completeness and integrity of the data that informs it. Delivering care with both data and discipline is not simply about quality; it is about financial integrity, operational predictability, and enterprise alignment.
Where This Shows Up Next
The impact of incomplete data doesn’t stop at governance. It shows up across revenue, supply chain performance, and forecasting.
- Stopping Revenue Leakage in the OR
- Why Hospitals Lose Money Without Real-Time Supply Data
- The Hidden Cost of Implant Mismanagement
- Why Supply Chain Data Isn’t Reaching the OR
- Why AI Fails Without Better Healthcare Data
About The Author
Guest article by: Dr. Geoffrey P. Cole
Geoffrey P. Cole, MD, MBA, is a board-certified neurosurgeon and former Chief Medical Officer at Piedmont Rockdale Hospital with over 40 years in clinical practice and healthcare leadership. He led major safety and quality initiatives across the Piedmont Healthcare system and is an Associate and Adjunct Professor in the Department of Health Policy and Management at the College of Public Health, University of Georgia. He is a member of IDENTI Medical’s Advisory Board.
